IndraLab

Statements


4 | 1 7 26

sparser
"USP37‐C‐Myc interactions might play an essential role in keloid pathogenesis, which could be used to design small molecules and peptidyl disruptors."

sparser
"The previously reported deubiquiting enzyme USP37 can directly bind to and deubiquitinate c-Myc, thereby stabilizing c-Myc ( Pan et al., 2015 )."

sparser
"Interestingly, unlike USP28 [ xref ], USP37 directly binds to c-Myc and acts independently of Fbw37."

trips
"Further studies indicate that USP37 directly interacts with c-Myc and deubiquitinates c-Myc in a DUB activity-dependent manner."

sparser
"USP37 interacts directly with MYC to promote its deubiquitination and maintain its protein stability ( xref )."

No evidence text available

No evidence text available

No evidence text available

No evidence text available

sparser
"Further studies indicate that USP37 directly interacts with c-Myc and deubiquitinates c-Myc in a DUB activity-dependent manner."

reach
"For example, Usp9x binds and stabilizes Mcl1, and Usp37 interacts with and deubiquitinates Myc [97,98] ."

sparser
"We further overexpressed myc-USP37 in U2OS cells and performed antigen capture using PCNA antibody, which was subsequently probed with myc antibody, and we observed an interaction between these two proteins (Fig.  xref E)."

sparser
"Given the structural properties of the interaction sites in the c-MYC-USP37 complex, a peptidyl inhibitor has been designed."

sparser
"Dissociation constant and free energy of the c-MYC-USP37 molecular complex was predicted to be 1.9 × 10 −8 Kda and −8.1 KJ, respectively."

reach
"Predicting c-MYC and USP37 Interaction."

sparser
"Disrupting c-MYC-USP37 Complex."

reach
"Since stabilization of c-MYC by USP37 is unwanted, disrupting the physical interaction between c-MYC and USP37 has therapeutic potential."

sparser
"Since the molecular interactions between c-MYC and USP37 are majorly driven by the intrinsically disordered regions in both proteins, instead of a small molecule, a peptidyl disruptor was designed."

reach
"Since the molecular interactions between c-MYC and USP37 are majorly driven by the intrinsically disordered regions in both proteins, instead of a small molecule, a peptidyl disruptor was designed."

reach
"This indicates that the predicted c-MYC USP37 complex is structurally plausible.The interaction between c-MYC and USP37 leads to post translational stabilization of the c-MYC, resulting in the abnormal increase in the half-life of the molecule, which is estimated to be 30 min in normal cells [54]."

reach
"Since the interacting region of c-MYC for USP37 is structurally disordered, it may not be a suitable target for small molecule inhibitor and/or disruptor [55]; rather, a peptidyl disruptor could be used to block the interaction between USP37 and c-MYC."

sparser
"HADDOCK prediction showed that peptide in majority of the simulations interacted with the c-MYC to the regions targeted (USP37 binding sites) and sits well within the cavity of c-MYC that binds with USP37."

sparser
"Therefore, it is plausible to conceive that in the ABC subtype of DLBCL the c-MYC may also interact with USP37, resulting in its stabilization."

sparser
"Moreover, interaction of c-MYC with USP37 is expected to remove ubiquitin tag from the protein via its catalytically active C19 domain."

sparser
"This indicates that the predicted c-MYC USP37 complex is structurally plausible."

sparser
"The interaction between c-MYC and USP37 leads to post translational stabilization of the c-MYC, resulting in the abnormal increase in the half-life of the molecule, which is estimated to be 30 min in normal cells [ xref ]."

sparser
"This retention of c-MYC with in cell leads to abnormal growth of the cells, and therefore, the interaction sites of c-MYC-USP37 complex could be targeted to prevent increased accumulation of c-MYC within the cells."

reach
"Further studies indicate that USP37 directly interacts with c-Myc and deubiquitinates c-Myc in a DUB activity dependent manner."

sparser
"This revealed that purified GST-USP37 bound to FLAG-CDC73 ( xref B) and purified GST-CDC73 bound to Myc-USP37 ( xref C) in E. coli strain BL21."

sparser
"Since the interacting region of c-MYC for USP37 is structurally disordered, it may not be a suitable target for small molecule inhibitor and/or disruptor [ xref ]; rather, a peptidyl disruptor could be used to block the interaction between USP37 and c-MYC."

sparser
"Reciprocal binding between CDC73 and USP37 was also detected in co-IP experiments performed in COS7 cells using FLAG-CDC73 and Myc-USP37 ( xref B)."

sparser
"Nearly 80% of the residues of c-MYC that interacts with USP37 have been found interacting with the designed peptide, suggesting that the peptide is specific to c-MYC-USP37 complex and could be used for targeted therapy against the ABC subtype of DLBCL."

sparser
"To see if CDC73 and USP37 colocalized in the cell, FLAG-CDC73 and Myc-USP37 vectors were simultaneously transfected into COS7 cells."

sparser
"After co-transfection of FLAG-CDC73 and Myc-USP37 expression vectors in COS7 cells, expression of CDC73 and USP37 proteins, respectively, was observed, thus showing that CDC73 and USP37 were co-expressed at the same location in the cell nucleus ( xref D)."

sparser
"Alanine scans of both the consensus regions showed inhibition in the interaction between c-MYC and USP37 when the residues Tyr177, Gln179, Asp180, Cys188, Asp251, Glu253, Glu254 and Glu255 were substituted with alanine ( xref D,E)."

sparser
"Predicting c-MYC and USP37 Interaction."

sparser
"Since stabilization of c-MYC by USP37 is unwanted, disrupting the physical interaction between c-MYC and USP37 has therapeutic potential."

sparser
"C-MYC-USP37 Intermolecular Complexes."